Cabot Corporation
At today's price, Cabot Corporation (CBT) is priced for -3.6% growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high. Built from SEC EDGAR filings.
• Cabot is a specialty-materials company built on carbon black, the reinforcing agent in tires, with a fast-growing battery-materials business attached; the 10-K ties carbon black demand to ⟦"the growth in vehicle production"⟧ and tire replacement, so the core is a bet on the auto cycle. • The most decisive split is between the two halves of the company: the core Reinforcement Materials segment faces weak tire demand and pricing pressure, while battery materials grew revenue 43% year over year i
Is CBT overvalued? See what's priced in →
358 institutional managers reported holding CBT in 13F filings for the quarter ended 2026-03-31. 44 opened new positions that quarter. Held by BlackRock, Vanguard Group, Wellington Management, among others. On the short side, 3.2M shares were sold short as of the 2026-06-15 count, about 6% of shares outstanding (6.4 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
CBT has cut its share count 8.3% over the past five years, spending $593.00M on repurchases. It pays a dividend, and has paid one every year in our records (17 and counting), raised 14 years straight; the current rate is $1.76 a share annually. Cash returned over the past three years: $260.00M in dividends and $491.00M in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
No open-market insider buys on file at CBT over the trailing three years. Absence is a fact about the company, not a signal. 19 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
CBT's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-09 | +1.8% | +0.2% |
| 2023-11-23 | +5.5% | -4.9% |
| 2024-02-09 | +5.7% | +16.9% |
| 2024-05-10 | +7.3% | -6.7% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
CBT's latest 8-K filings: 2026-05-14 (items 1.01, 1.02, 2.03, 9.01); 2026-05-05 (items 2.02, 9.01); 2026-03-17 (items 5.07); 2026-02-03 (items 2.02, 9.01); 2026-01-14 (items 5.02).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.